Position in FDMT
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$6,690,163
+$3,474,400 QoQ
Shares Held
503,020
+45.6% QoQ
Ownership
0.697%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 158 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 80%
Shared 0%
None 20%
Common Shares in FDMT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,716,934,888 across 523 Biotechnology names. FDMT ranks #155 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in FDMT
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,690,163 | 503,020 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $3,215,763 | 345,410 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,045,210 | 672,695 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $7,264,063 | 835,911 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $3,430,543 | 924,676 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $5,738,877 | 1,776,743 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $10,377,224 | 1,863,057 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $18,402,279 | 1,702,339 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $30,650,307 | 1,460,234 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $49,374,267 | 1,549,726 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $31,783,560 | 1,568,784 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $18,660,494 | 1,465,868 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $28,329,403 | 1,567,759 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $29,942,860 | 1,741,877 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $32,394,881 | 1,458,572 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $16,253,444 | 2,021,573 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,185,006 | 313,039 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $6,350,942 | 420,036 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $9,523,668 | 434,078 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $9,937,121 | 368,451 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $10,373,349 | 430,787 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $11,805,693 | 272,146 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $10,184,472 | 245,705 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||